SCIENION Appoints Frauke Hein as CEO
Hein to lead as SCIENION plans for long-term profitable growth
BERLIN, June 1st, 2022. SCIENION GmbH, a BICO company and the precision liquid handling technology company powering life sciences and diagnostics for the future of health, today appointed Dr. Frauke Hein as co-Chief Executive Officer (CEO) alongside current CEO Dr. Holger Eickhoff, effective immediately. Hein and Eickhoff will lead the firm as co-CEOs during a transition period, after which Frauke Hein will take the helm as CEO and Holger Eickhoff will be focusing on leading and growing the BICO Bioautomation Business Area.
Dr. Frauke Hein is an executive, investor and entrepreneur in the life science industry with a track record of achievements in management, business, research and development, and is highly regarded for her leadership skills and business management experience.
She joins SCIENION from her former position as Chief Business Officer at Adrenomed AG, a clinical stage biotech company she cofounded in 2009, pioneering the development of a precision medicine guided first-in-class drug. Previously Frauke Hein gained expertise at the diagnostic company BRAHMS AG and global life science corporation Thermo Fisher Scientific as Director R&D at both companies. Before that she served as Director Life Sciences at Brandenburg Economic Development Board, advising financing and strategic planning for innovative biotech and medtech start-ups including technology and market assessment for Venture Capital. Frauke Hein studied biology at Westfälische Wilhelms University of Münster and holds a Diploma in Biology and a PhD in Biology with focus on biochemistry, biotechnology and molecular biology.
At SCIENION, Hein will assume leadership over the business organization and core corporate functions. She will use her deep experience working with global companies to drive SCIENION’s growth, expand the company’s suite of products, and serve customers who are scaling businesses in today’s life science markets, all in close collaboration with Eickhoff.
“I have known Frauke professionally for over 20 years and have great admiration and respect for her accomplishments and her values. We share a vision of how the life sciences and diagnostics world is transforming global health, how technology providers have a bigger role to play, and how today’s great companies must be built around customer and employee centricity. I am excited to partner with Frauke as SCIENION continues to build tailored platforms to create the future of health,” stated Holger Eickhoff, CEO of SCIENION.
“I am delighted to welcome Frauke to SCIENION. She is an inspiring leader and experienced company-builder. SCIENION is a global brand trusted by over 1000 diagnostic and life science customers. BICO is confident that Frauke and Holger will be a great team that will leverage SCIENION’s assets and current momentum to lead us into our next chapter of growth,” said Erik Gatenholm, CEO of BICO.
“I’m thrilled to be joining SCIENION and I am honored to partner with Holger, the SCIENION and BICO team to do just that: carrying on the company’s mission of bringing a universe of precision liquid handling solutions to diagnostic, pharma and life science businesses of any size, anywhere in the world. We have the can-do spirit, capability, trusted brand, talented and diverse global team to engage and serve businesses worldwide, and in doing so create shareholder value for many years to come,” added Frauke Hein.
Founded in 2001, SCIENION is a renowned specialist in ultra-low volume precision liquid handling in the pico-liter to micro-liter range, enabling applications from research to high-throughput production of assays in diagnostics and life sciences. Addressing the dynamically increasing needs for miniaturization and multiplex analyses, SCIENION is an ISO 9001:2015 certified complete solution provider offering a unique portfolio of automated precision dispensing systems, readers, consumables, assay development and contract manufacturing services. The company operates from two sites in Germany, Berlin and Dortmund, and has subsidiaries in Phoenix, Arizona (USA), Chichester (UK), and Lyon (France). The French subsidiary Cellenion offers solutions for single cell analyses, e.g. with the single cell dispenser cellenONE and products such as cellenCHIP and proteoCHIP for omics-based applications.
SCIENION is part of BICO, the leading bio convergence company in the world that provides technologies, products and services to create the future of health.
Founded in 2016, BICO (formerly CELLINK) is enabling the future of life-saving treatments by reducing the organ shortage and accelerating drug development by providing accessible life science solutions that combine biology and technology (bioconvergence). The company focuses on developing, manufacturing, selling, and supporting its life sciences equipment, consumables, and reagents for both manufacturing as well as research purposes. BICO has more than 25,000 products in the field, sales in more than 65 countries, delivers to all top 20 pharmaceutical companies, and have been cited in more than 10,000 scientific publications. BICO is listed on Nasdaq Stockholm under: BICO.
Phone: +49 (0)30 – 6392 1700
Phone +49 (0)30 – 6120 1081
Mobile +49 (0)174 3017754